Clinical trial Recruiting at 1 site Observational Ages 40 to 75

AI-assisted EGGIM scoring for gastric intestinal metaplasia

Official title: Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score

Run by Qilu Hospital of Shandong University · NCT07257796 · Data updated 2026-11-12

This study tests if an AI tool can automatically calculate EGGIM scores from endoscopy images to measure gastric intestinal metaplasia in adults undergoing image-enhanced endoscopy.

Quick facts

Study typeObservational
Ages40 Years to 75 Years
SexAll
Enrollment3000 (estimated)
SponsorQilu Hospital of Shandong University
Academic / other
Locations3 sites (Jinan, Shandong and 2 other locations)
StatusRecruiting
StartedNovember 1, 2025
Main results expectedMay 31, 2027
Study endsDecember 31, 2027
Registry record updatedDecember 2, 2025
Trial IDNCT07257796 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 40–75 years old who are undergoing image-enhanced endoscopy (IEE) and can give informed consent, without prior gastric surgery and without severe organ dysfunction, are the ideal candidates.

Probably not a fit

People outside the 40–75 age range, unable to undergo gastroscopy or IEE, with prior stomach surgery, or with severe cardiac, cerebral, pulmonary, renal, or psychiatric disorders are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, multicenter validation of an artificial intelligence system that automatically reads endoscopic images and generates EGGIM scores for gastric intestinal metaplasia. Adults aged 40–75 undergoing image-enhanced endoscopy at three hospitals in Jinan will be enrolled after informed consent. The AI-generated scores will be compared with endoscopists' readings and, where available, histology to measure accuracy, consistency, and reliability. The protocol expands on preliminary pilot data from a prior investigation (NCT05464108).

Why it matters

Potential benefit: If successful, the AI could make EGGIM scoring faster and more consistent, helping clinicians detect precancerous gastric changes earlier.

How similar studies have gone: Previous pilot work (NCT05464108) and other AI applications in endoscopy have shown promise, but this larger multicenter validation is needed to confirm performance.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients aged 40-75 years who undergo the IEE examination
* patients who voluntarily sign the informed consent form

Exclusion Criteria:

* patients with severe cardiac, cerebral, pulmonary or renal dysfunction or psychiatric disorders who cannot participate in gastroscopy
* patients with previous surgical procedures on the stomach

Where it's running

  • Qilu Hospital of Shandong University
    Jinan, Shandong, China
    Recruiting
  • Shandong First Medical University First Affiliated Hospital
    Jinan, Shandong, China
    Not yet recruiting
  • Shandong Second Provincial General Hospital
    Jinan, Shandong, China
    Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.